ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 22

Protective Properties of Conditioned Media From Adipose Stem Cells On Osteoarthritic Chondrocytes

Maria Isabel Guillén1, Julia Platas1, Vicente Mirabet2, Miguel Angel Castejón3, Francisco Gomar4 and Maria Jose Alcaraz1, 1Pharmacology, University of Valencia, Burjasot, Valencia, Spain, 2Generalitat Valenciana, Valencia, Spain, 3De la Ribera University Hospital, Alzira, Spain, 4Surgery, University of Valencia and University Hospital, Valencia, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: cartilage, chondrocytes, Inflammation, Mesenchymal stem cells and osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Biology and Pathology of Bone and Joint

Session Type: Abstract Submissions (ACR)

Background/Purpose: Adipose-derived mesenchymal stem cells (ASC) exhibit a high potential for cell therapy and they might also act as a cellular source for supplying soluble factors exerting anti-inflammatory or trophic effects on cells. Osteoarthritis (OA) involves the destruction of articular cartilage leading to disability. The purpose of this study was  to investigate whether conditioned medium from adipose-derived mesenchymal stem cells (ASC-CM) improves the inflammatory and degradative response induced by interleukin-1β in OA chondrocytes and cartilage.

Methods: Adipose tissue from patients subjected to abdominal lipectomy surgery, was used for ASC isolation by collagenase treatment. Cells were incubated in DMEM/F12 containing 15% human serum. Cell phenotype was analyzed by flow cytometry with specific antibodies anti-CD105-PE, anti-CD90PerCP-eFluo 710, anti-CD34APC, and anti-CD45-PE (International Society of Cellular Therapy), and cellular viability with propidium iodide. The conditioned medium (ASC-CM) was collected after 48h of culture, centrifuged and stored at -80ºC in sterile conditions. Cartilage specimens were obtained from patients with diagnosis of advanced OA. Protocols were approved by the Institutional Ethical Committee. Chondrocytes were used in primary culture. Cartilage explants or isolated chondrocytes were stimulated with 10 ng/ml interleukin (IL)-1β for different times. Gene expression was analyzed by real-time PCR. Protein expression was investigated by ELISA. Nitric oxide (NO) production and matrix metalloproteinase (MMP) activity were measured as microplate fluorescence assays. Prostaglandin E2 (PGE2) was evaluated by RIA.

Results: IL-1β significantly increased the production of NO, PGE2 and MMP activity,  and the expression of IL-1β, tumor necrosis factor-α (TNFα), vascular endothelial growth factor (VEGF) and a wide range of chemokines, after 24h, with respect to basal conditions. ASC-CM treatment of OA explants or chondrocytes reduced the production of NO which was dependent on inducible NO synthase down-regulation. In addition, PGE2levels as well as MMP activity were significantly decreased. A lower expression of IL-1β, TNFα, VEGF and chemokines CCL-4, CCL-5, CCL-8, CCL-19, CCL-20, CXCL-1, CXCL-2, CXCL-3 and CXCL-8 was observed in chondrocytes treated with ASC-CM with respect to IL-1β controls. We have also evaluated the senescence marker β-galactosidase. In cells treated with IL-1β and ASC-CM for 7 days, we observed a significant reduction in senescence-associated β-galactosidase activity in comparison with chondrocytes treated with IL-1β.

Conclusion: The results of our study demonstrate the down-regulation of inflammatory and catabolic mediators by ASC-CM in OA explants and chondrocytes. Our data have revealed a protective role for ASC-CM in chondrocytes suggesting possible applications against cartilage degradation.


Disclosure:

M. I. Guillén,
None;

J. Platas,
None;

V. Mirabet,
None;

M. A. Castejón,
None;

F. Gomar,
None;

M. J. Alcaraz,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/protective-properties-of-conditioned-media-from-adipose-stem-cells-on-osteoarthritic-chondrocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology